A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults (NCT07464314)
A Phase 1, Observer-Blind, Randomized, Controlled Study to Evaluate the Safety and Immunogenicity of an Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
🩺 Plain-English Summary (8th-Grade Level)
This early-stage study will look at a new mRNA vaccine that combines defenses against both seasonal flu and COVID-19 in terms of its safety and how it builds protection. Healthy adults aged 65 to 85 will receive different doses of this new vaccine, a standard flu vaccine, or COVID-19 vaccine. The study will assess any side effects or health issues, and additional blood samples will be collected at specific times to evaluate how well participants bodies build protection against the flu and COVID-19.
Who can join: Review the eligibility criteria below.
Location: GSK Investigational Site — Anniston, Alabama
Age range: 65 Years to 85 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (12 Sites)
- GSK Investigational Site — Anniston, Alabama
- GSK Investigational Site — Little Rock, Arkansas
- GSK Investigational Site — Fair Oaks, California
- GSK Investigational Site — San Diego, California
- GSK Investigational Site — Miami, Florida
- GSK Investigational Site — Miami Lakes, Florida
- GSK Investigational Site — West Palm Beach, Florida
- GSK Investigational Site — Stockbridge, Georgia
- GSK Investigational Site — Austin, Texas
- GSK Investigational Site — Charlottesville, Virginia
- GSK Investigational Site — Newport News, Virginia
- GSK Investigational Site — Seattle, Washington
📞 Contact the Study Coordinator
Phone: (877) 379-3718
Email: GSKClinicalSupportHD@gsk.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
Explore by condition: All Influenza, Human+COVID-19 clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.